These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11158401)

  • 1. Variation in the progression of diabetic nephropathy according to racial origin.
    Earle KK; Porter KA; Ostberg J; Yudkin JS
    Nephrol Dial Transplant; 2001 Feb; 16(2):286-90. PubMed ID: 11158401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus.
    Mehrotra S; Ling KL; Bekele Y; Gerbino E; Earle KA
    Diabet Med; 2001 Feb; 18(2):109-15. PubMed ID: 11251673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
    Bakris GL; Mangrum A; Copley JB; Vicknair N; Sadler R
    Hypertension; 1997 Mar; 29(3):744-50. PubMed ID: 9052890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta-analysis.
    Jadawji C; Crasto W; Gillies C; Kar D; Davies MJ; Khunti K; Seidu S
    Diabetes Obes Metab; 2019 Mar; 21(3):658-673. PubMed ID: 30407709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin.
    Earle KA; Mehrotra S; Dalton RN; Denver E; Swaminathan R
    J Am Soc Nephrol; 2001 Oct; 12(10):2125-2130. PubMed ID: 11562411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy.
    Koppiker N; Feehally J; Raymond N; Abrams KR; Burden AC
    Diabet Med; 1998 Jan; 15(1):60-5. PubMed ID: 9472865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy.
    Chandie Shaw PK; van Es LA; Paul LC; Rosendaal FR; Souverijn JH; Vandenbroucke JP
    Diabetologia; 2003 May; 46(5):618-24. PubMed ID: 12739019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study.
    Chan JC; Wat NM; So WY; Lam KS; Chua CT; Wong KS; Morad Z; Dickson TZ; Hille D; Zhang Z; Cooper ME; Shahinfar S; Brenner BM; Kurokawa K;
    Diabetes Care; 2004 Apr; 27(4):874-9. PubMed ID: 15047641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.
    Rodby RA; Rohde RD; Clarke WR; Hunsicker LG; Anzalone DA; Atkins RC; Ritz E; Lewis EJ
    Nephrol Dial Transplant; 2000 Apr; 15(4):487-97. PubMed ID: 10727543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating vitamin E, transforming growth factor beta1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes.
    Zitouni K; Harry DD; Nourooz-Zadeh J; Betteridge DJ; Earle KA
    Kidney Int; 2005 May; 67(5):1993-8. PubMed ID: 15840049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
    Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
    Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
    Kaperonis N; Bakris G
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):79-84. PubMed ID: 12496670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus.
    Dreyer G; Hull S; Mathur R; Chesser A; Yaqoob MM
    Diabet Med; 2013 Aug; 30(8):956-63. PubMed ID: 23600455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in the +405 and -460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom.
    Zitouni K; Tinworth L; Earle KA
    BMC Neurol; 2017 Jun; 17(1):125. PubMed ID: 28662688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.